Aug 21, 2026 04:03AM
May 30, 2026 08:09PM
May 27, 2026 06:40AM
Apr 21, 2026 12:45PM
Mar 21, 2026 07:27AM
Mar 21, 2026 07:26AM
Dec 9, 2025 05:00AM Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025
Sep 9, 2025 06:00AM
Aug 6, 2025 07:02AM
Jul 2, 2025 08:08PM
Jun 19, 2025 06:08AM
Jun 12, 2025 06:13AM
May 15, 2025 06:09AM
Mar 20, 2025 06:00AM Dizal's Golidocitinib in Combination with Anti-PD-1 Shows Promise in IO Resistant Non-Small Cell Lung Cancer
Jan 7, 2025 05:00AM
Nov 8, 2024 05:01AM
Oct 13, 2024 04:04AM
Sep 17, 2024 03:47AM
Jun 19, 2024 07:30AM
Jun 2, 2024 06:18AM
Apr 24, 2024 10:10AM Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting
Apr 7, 2024 07:09AM
Dec 12, 2023 05:00AM
Dec 10, 2023 05:00AM
Sep 21, 2023 08:26AM
Sep 14, 2023 05:07AM
Sep 10, 2023 05:03AM
Aug 23, 2023 07:21AM Dizal's Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with EGFR Exon20ins Mutations
Aug 17, 2023 05:10AM
Jun 7, 2023 04:45AM
May 25, 2023 06:00PM
Apr 26, 2023 07:20PM
Jan 10, 2023 04:03AM
Sep 5, 2022 10:49AM
Aug 5, 2022 12:07AM Dizal Demonstrates Clinical Update for Sunvozertinib (DZD9008) in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 WCLC
May 13, 2022 07:09AM
May 5, 2022 07:00AM
Feb 18, 2022 07:00AM
Jan 27, 2022 08:06AM

332,802 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All